- Exchange: Berlin
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Snapshot for QRxPharma Ltd (EYJ)
| Open: | 0.853 | Day's Range: | 0.853 - 0.853 | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | 0.894 | 52wk Range: | 0.460 - 1.407 | 1-Yr Rtn: | -34.59% |
Key Statistics for EYJ
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(06/2013) | - |
| Relative P/E vs. DAX | - |
| Earnings Per Share (AUD) (ttm) | - |
| Est. EPS (AUD) (06/2013) | -0.0810 |
| Est. PEG Ratio | - |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 0 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/30/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for EYJ
No data available
Company Profile & Key Executives for EYJ
QRxPharma Limited is a specialty pharmaceutical company developing and commercializing pain therapy products. The Company's preclinical and clinical pipeline includes other technologies in the fields of neurodegenerative disease and venomics.
| John W HoladayManaging Director/CEO | Chris J CampbellCFO/Secretary |
| Edward M RudnicChief Operating Officer | Richard A PaulExec VP:Drug Development |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
EYJ News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page